Suppr超能文献

在接受抗逆转录病毒治疗(ART)的慢性感染者中,对 3BNC117 和 10-1074 的敏感性。

Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons.

机构信息

University of Pennsylvania.

The Wistar Institute, Philadelphia, PA.

出版信息

AIDS. 2023 Jul 1;37(8):1203-1207. doi: 10.1097/QAD.0000000000003575. Epub 2023 Apr 11.

Abstract

OBJECTIVE

The aim of this study was to assess the susceptibility of HIV to two HIV monoclonal antibodies (bnAbs), 3BNC117 and 10-1074, in individuals with chronically antiretroviral therapy (ART) suppressed HIV infection.

DESIGN

The susceptibility of bnAbs was determined using the PhenoSense mAb Assay, which is a cell-based infectivity assay designed to assess the susceptibility of luciferase-reporter pseudovirions. This assay is the only Clinical Laboratory Improvement Ammendment (CLIA)/College of American Pathologist (CAP) compliant screening test specifically developed for evaluating bnAb susceptibility in people with HIV infection.

METHOD

The susceptibility of luciferase-reporter pseudovirions, derived from HIV-1 envelope proteins obtained from peripheral bloodmononuclear cells of 61 ART-suppressed individuals, to 3BNC117 and 10-1074 bnAbs was assessed using the PhenoSense mAb assay. Susceptibility was defined as an IC 90 of <2.0 μg/ml and 1.5 μg/ml for 3BNC117 and 10-1074, respectively.

RESULTS

About half of the individuals who were chronically infected and virologically suppressed were found to harbor virus with reduced susceptibility to one or both of the tested bnAbs.

CONCLUSIONS

The reduced combined susceptibility of 3BNC117 and 10-1074 highlights a potential limitation of using only two bnAbs for pre-exposure prophylaxis or treatment. Further studies are needed to define and validate the clinical correlates of bnAb susceptibility.

摘要

目的

本研究旨在评估两种 HIV 单克隆抗体(bnAb),即 3BNC117 和 10-1074,在慢性抗逆转录病毒治疗(ART)抑制 HIV 感染个体中的敏感性。

设计

使用 PhenoSense mAb 测定法来确定 bnAb 的敏感性,该测定法是一种基于细胞的感染性测定法,旨在评估报告荧光素酶的假病毒对 HIV 的敏感性。该测定法是唯一经过临床实验室改进修正案(CLIA)/美国病理学家学会(CAP)认证的筛选检测方法,专门用于评估 HIV 感染者中 bnAb 的敏感性。

方法

使用 PhenoSense mAb 测定法评估来自 61 名慢性 ART 抑制个体外周血单个核细胞中 HIV-1 包膜蛋白的报告荧光素酶假病毒对 3BNC117 和 10-1074 bnAb 的敏感性。将敏感性定义为对 3BNC117 和 10-1074 的 IC90 分别<2.0μg/ml 和 1.5μg/ml。

结果

约一半的慢性感染和病毒学抑制的个体被发现携带对一种或两种测试的 bnAb 敏感性降低的病毒。

结论

3BNC117 和 10-1074 的联合敏感性降低突出了仅使用两种 bnAb 进行暴露前预防或治疗的潜在局限性。需要进一步研究来定义和验证 bnAb 敏感性的临床相关性。

相似文献

本文引用的文献

9
The expanding array of HIV broadly neutralizing antibodies.HIV 广谱中和抗体的不断增多。
Retrovirology. 2018 Oct 16;15(1):70. doi: 10.1186/s12977-018-0453-y.
10
Combination therapy with anti-HIV-1 antibodies maintains viral suppression.联合使用抗 HIV-1 抗体可维持病毒抑制。
Nature. 2018 Sep;561(7724):479-484. doi: 10.1038/s41586-018-0531-2. Epub 2018 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验